Technology
Health
Biotechnology

Precipio

$0.1405
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0073 (-4.94%) Today
-$0.0073 (-4.94%) Today

Why Robinhood?

You can buy or sell Precipio and other stocks, options, ETFs, and crypto commission-free!

About

Precipio, Inc. Common Stock, also called Precipio, is a cancer diagnostics company, which engages in the development and provision of a platform designed to eradicate the problem of misdiagnosis. Read More Its products include MX-ICP and ICEme kits. The company was founded in March 1997 and is headquartered in New Haven, CT.

Employees
33
Headquarters
New Haven, Connecticut
Founded
1997
Market Cap
3.51M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.53M
High Today
$0.1468
Low Today
$0.1357
Open Price
$0.1457
Volume
996.36K
52 Week High
$0.68
52 Week Low
$0.1357

Collections

Technology
Health
Biotechnology
Cancer Prevention
2014 IPO
US
North America

News

Associated PressMar 11

Precipio CEO Issues Shareholder Update Letter

This content is a press release from our partner Globe Newswire. The AP newsroom and editorial departments were not involved in its creation. This content is a press release from our partner Globe Newswire. The AP newsroom and editorial departments were not involved in its creation. NEW HAVEN, Conn., March 11, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), issues the following letter from CEO Ilan Danieli. Dear Shareholders, Following our recent quarterly confere...

3,753
MarketBeatMar 7

Stock Price, News, & Analysis for Precipio

News stories about PRPO stock have been trending somewhat positive on Saturday, InfoTrie reports. The research firm identifies positive and negative press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Precipio earned a daily sentiment score of 0.6 on InfoTrie's scale. They also gave media headlines about the biotechnology company a news buzz of 10.0 ...

320
Associated PressMar 5

Continued ICP Orders From Japanese Customers

NEW HAVEN, Conn., March 05, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: PRPO ), announced today that it continues to receive both new and repeat business from customers in Japan for its ICP liquid biopsy enrichment technology. In Particular, Precipio’s EGFR Exon 20 assay is proving to be of substantial clinical interest in the Japanese hospital market. Recently, Kyorin University Hospital in Tokyo, placed its third order for Precipio’s ICP assay. The RUO reagents kit wil...

260

Earnings

-$1.01
-$0.73
-$0.45
-$0.17
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
-$1.01 per share
Actual
Expected Mar 28, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.